monoesters of C16 and C18 (branched and linear) fatty acids with decan-1-ol

Endpoint summary

Description of key information

Skin (in vitro, OECD 439): not irritating

Eye (in vitro, OECD 492): not irritating

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records

Reference

Endpoint:

skin irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

30 Mar - 04 Apr 2011

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Test system:

human skin model

Source species:

human

Cell type:

non-transformed keratinocytes

Details on animal used as source of test system:

The EPISKINTM model is a three-dimensional reconstructed human epidermis model
consisting of adult human-derived epidermal keratinocytes seeded on a dermal
substitute consisting of a collagen type I matrix coated with type IV collagen. A highly
differentiated and stratified epidermis model is obtained after a 13-Day culture period
comprising of the main basal, supra basal, spinous and granular layers and a functional
stratum corneum.
EPISKINTM MODEL KIT
Date received : 29 March 2011

Vehicle:

unchanged (no vehicle)

Details on test system:

PROCEDURE
Pre-Test
Assessment of Direct Test Item Reduction of MTT
MTT dye metabolism, cell viability assay
The MTT assay, a colourimetric method of determining cell viability, is based on
reduction of the yellow tetrazolium salt (344,5-dimethylthiazol-2-y1]-2,5-diphenyltetrazolium
bromide) to a blue formazan dye by mitochondrial succinate dehydrogenase
in viable cells.
One limitation of the assay is possible interference of the test item with MTT. A test item
may directly reduce MTT, thus mimicking dehydrogenase activity of the cellular
mitochondria. This property of the test item is only a problem, if at the time of the MTT
test (after rinsing) there are still sufficient amounts of the test item present on or in the
tissues. In this case, the true metabolic MTT reduction and the false direct MTT
reduction can be differentiated and quantified.

Test for Direct MTT Reduction
As specified, a test item may interfere with the MTT endpoint, if it is able to directly
reduce MTT and at the same time is present on or in the tissues when the MTT viability
test is performed. To identify this possible interference, each test item is checked for the
ability to directly reduce MTT according to the following procedure:
10 µl of the test item was added to 2 ml of a 0.3 mg/ml MTT solution freshly prepared in
assay medium. The solution was incubated in the dark at 37°C, 5% CO2 in air for
3 hours. Untreated MTT solution was used as a control.
If the MTT solution containing the test item turns blue, the test item is presumed to have
reduced the MTT.

The test item was shown to directly reduce MTT in the direct MTT reduction test. There
was a possibility that if the test item could not be totally rinsed off the tissues, any
residual test item present on or in the tissue may directly reduce MTT and could have
given rise to a false negative result. Therefore the determination of skin irritation
potential was performed in parallel on viable and water-killed tissues.
This step was a functional check which employs water-killed tissues that possess no
metabolic activity but absorb and bind the test substance like viable tissues.
Water-killed tissues were prepared by placing untreated EPISKINTM tissues in a 12-well
plate containing 2.2 ml of sterile distilled water in each well. The tissues were Incubated
at 37°C, 5% CO2 in air for 48 hours ± 1 hour. At the end of the incubation the water was
discarded. Once killed the tissues were stored in a freezer (-14 to -30°C) for up to
6 months. Before use each tissue was thawed by placing in 2.2 ml of maintenance
medium for approximately 1 hour at room temperature.
In addition to the normal test procedure, each MTT reducing test substance was applied
to a water-killed tissue. In addition, one water-killed tissue remained untreated. The
untreated water-killed control showed a small amount of MTT reduction due to residual
reducing enzymes within the killed tissue.

Pre-Incubation (Day 0: tissue arrival)
2 ml of maintenance medium, warmed to approximately 37°C, was pipetted into the first
column of 3 wells of a pre-labelled 12-well plate. Each epidermis unit was transferred
into the maintenance medium filled wells (3 units per plate). A different 12-well plate was
used for the test item and each control item. The tissues were incubated at 37°C,
5% CO2 in air overnight.
Main Test
5.2.1 Application of Test Item and Rinsing (Day 1)
2 ml of maintenance medium, warmed to approximately 37°C, was pipetted into the
second column of 3 wells of the 12-well plate.
Triplicate tissues were treated with the test item for an exposure period of 15 minutes.
The test item was applied topically to the corresponding tissues ensuring uniform
covering. 10 µl of the test item was applied to the epidermis surface. Triplicate tissues
treated with 10 µl of PBS served as the negative controls and triplicate tissues treated
with 10 µl of SDS 5% w/v served as the positive controls. To ensure satisfactory contact
with the positive control item the SDS solution was spread over the entire surface of the
epidermis using a pipette tip (taking particular care to cover the centre). After 7 minutes
contact time the SDS solution was re-spread with a pipette tip to maintain the distribution
of the SDS for the remainder of the contact period. The plate(s) were kept in the
biological safety cabinet at room temperature for 15 minutes.
At the end of the exposure period, each tissue was removed from the well using forceps
and rinsed using a wash bottle containing PBS with Ca' and Mg'. Rinsing was
achieved by filling and emptying each tissue insert for approximately 40 seconds using a
constant soft stream of PBS to gently remove any residual test item. The rinsed tissues
were transferred to the second column of 3 wells containing 2 ml of maintenance
medium in each well. The rinsed tissues were incubated at 37°C, 5% CO2 in air for
42 hours.

MTT Loading/Formazan Extraction (Day 3)
Following the 42-Hour post-exposure incubation period each 12-well plate was placed
onto a plate shaker for 15 minutes to homogenise the released mediators in the
maintenance medium. 1.6 ml of the maintenance medium from beneath each tissue was
transferred to pre-labelled micro tubes and stored in a freezer at -14 to -30°C for possible
inflammatory mediator determination.
2 ml of a 0.3 mg/ml MTT solution, freshly prepared in assay medium, was pipetted into
the third column of 3 wells of the 12 well plate(s). The tissues were transferred to the
MTT filled wells, being careful to remove any excess maintenance medium from the
bottom of the tissue insert by blotting on absorbent paper. The tissues were incubated
for 3 hours at 37°C, 5% CO2 in air. At the end of the 3-Hour incubation period each
tissue was placed onto absorbent paper to dry. A total biopsy of the epidermis was
made using the EPISKINTM biopsy punch. The epidermis was carefully separated from
the collagen matrix using forceps and both parts (epidermis and collagen matrix) placed
into labelled 1.5 ml micro tubes containing 500 µl of acidified isopropanol, ensuring that
both the epidermis and collagen matrix were fully immersed. Each tube was plugged to
prevent evaporation and mixed thoroughly on a vortex mixer. The tubes were
refrigerated at 1 to 10°C until Day 6 of the experiment, allowing the extraction of
formazan crystals out of the MTT-loaded tissues.

Absorbance/Optical Density Measurements (Day 6)
At the end of the formazan extraction period each tube was mixed thoroughly on a vortex
mixer to produce a homogenous coloured solution.
For each tissue, duplicate 200 µl samples were transferred to the appropriate wells of a
pre-labelled 96-well plate. 200 µl of acidified isopropanol alone was added to the two
wells designated as 'blanks'. The optical density was measured (quantitative viability
analysis) at 540 nm (without a reference filter) using the Anthos 2001 microplate reader.

Control samples:

yes, concurrent negative control

yes, concurrent positive control

Amount/concentration applied:

10 µl of the test item was applied to the epidermis surface.
Triplicate tissues treated with 10 µl of PBS served as the negative controls.
triplicate tissues treated with 10 µl of SDS 5% w/v served as the positive controls

Duration of treatment / exposure:

15 minutes

Duration of post-treatment incubation (if applicable):

incubated at 37°C, 5% CO2 in air for 42 hours.

Number of replicates:

3

Irritation / corrosion parameter:

% tissue viability

Run / experiment:

experiment 1

Value:

94.8

Vehicle controls validity:

not applicable

Negative controls validity:

valid

Positive controls validity:

valid

Irritation / corrosion parameter:

% tissue viability

Run / experiment:

experiment 2

Value:

94.1

Vehicle controls validity:

not applicable

Negative controls validity:

valid

Positive controls validity:

valid

Irritation / corrosion parameter:

% tissue viability

Run / experiment:

experiment 3

Value:

91.9

Vehicle controls validity:

not applicable

Negative controls validity:

valid

Positive controls validity:

valid

Other effects / acceptance of results:

Direct MTT Reduction
An assessment found the test item was able to directly reduce MTT. Therefore, an
additional procedure using water-killed tissues was performed during the determination
of skin irritation potential. However, the results obtained showed no degree of
interference due to direct reduction of MTT occurred. It was therefore considered
unnecessary to use the results of the water-killed tissues for quantitative correction of
results or for reporting purposes.

Test Item, Positive Control Item and Negative Control Item
The relative mean viability of the test item treated tissues was 93.6% after a 15-Minute
exposure period.

Quality Criteria
The relative mean tissue viability for the positive control treated tissues was ≤40%
relative to the negative control treated tissues and the standard deviation value of the
percentage viability was ≤18%. The positive control acceptance criterion was therefore
satisfied.
The mean OD540 for the negative control treated tissues was ≥0.6 and the standard
deviation value of the percentage viability was ≤18%. The negative control acceptance
criterion was therefore satisfied.
The standard deviation calculated from individual percentage tissue viabilities of the
three identically treated tissues was ≤18%. The test item acceptance criterion was
therefore satisfied.

Mean OD₅₄₀ Values and Percentage Viabilities for the Negative

Control Item, Positive Control Item and Test Item

Item	OD540of tissues	Mean OD540 of triplicate tissues	± SD of 0D540	Relative individual tissue viability (%)	Relative mean viability (%)	± SD of
						Relative
						mean
						viability (%)
Negative Control Item	0.777	0.75	0.024	103.6	100*	3.2
	0.732			97.6
	0.74			98.7
Positive Control Item	0.05	0.049	0.006	6.7	6.6	0.1
	0.049			6.5
	0.049			6.5
Test Item	0.711	0.702	0.012	94.8	93.6	1.5
	0.706			94.1
	0.689			91.9

SD = Standard deviation

* = The mean viability of the negative control tissues is set at 100%

Interpretation of results:

other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008

Executive summary:

Introduction

The purpose of this test was to evaluate the skin irritation potential of the

test item using the EPISKIN^TM reconstructed human epidermis model after a treatment

period of 15 minutes followed by a post-exposure incubation period of 42 hours. The

principle of the assay was based on the measurement of cytotoxicity in reconstructed

human epidermal cultures following topical exposure to the test item by means of the

colourimetric MTT reduction assay. Cell viability is measured by enzymatic reduction of

the yellow MTT tetrazolium salt (3[4,5-dimethylthiazol-2-y1]-2,5-diphenyktetrazolium

bromide) to a blue formazan salt (within the mitochondria of viable cells) in the test item

treated tissues relative to the negative controls. The concentration of the inflammatory

mediator IL-lα in the culture medium retained following the 42-Hour post-exposure

incubation period is also determined for test items which are found to be borderline nonirritant

based upon the MTT reduction endpoint. This complimentary end-point will be

used to either confirm a non-irritant result or will be used to override the non-irritant

result.

Method

Triplicate tissues were treated with the test item for an exposure period of

15 minutes. At the end of the exposure period each tissue was rinsed before incubating

for 42 hours. At the end of the post-exposure incubation period each tissue was taken

for MTT-loading. The maintenance medium from beneath each tissue was transferred to

pre-labelled micro tubes and stored in a freezer for possible inflammatory mediator

determination. After MTT loading a total biopsy of each epidermis was made and placed

into micro tubes containing acidified isopropanol for extraction of formazan crystals out of

the MTT-loaded tissues.

At the end of the formazan extraction period each tube was mixed thoroughly and

duplicate 200 pl samples were transferred to the appropriate wells of a pre-labelled

96-well plate. The optical density was measured at 540 nm.

Data are presented in the form of percentage viability (MTT reduction in the test item

treated tissues relative to negative control tissues).

Results

The relative mean viability of the test item treated tissues was 93.6% after the

15-Minute exposure period.

Quality criteria

The quality criteria required for acceptance of results in the test were

satisfied.

Conclusion

The test item was considered to be Non-Irritant (NI).

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records

Reference

Endpoint:

eye irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

10 - 12 May 2011

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Species:

human

Details on test animals or tissues and environmental conditions:

The SkinEthic HCE model consists of transformed human corneal epithelial cells of the
cell line HCE (LSU EYE Center, New Orleans, USA) that form a corneal epithelial tissue
(mucosa), devoid of stratum corneum, resembling, histologically, the mucosa of the
human eye. The test item is applied directly to the culture surface, at the air interface, so
that undiluted and/or end use dilutions can be tested directly. The model consists of an
airlifted, living, corneal tissue construct, produced in polycarbonate inserts in serum-free
and chemically defined medium.

SKINETHIC HCE MODEL
Supplier: SkinEthic Laboratories, Nice, France
Date Received: 10 May 2011

Receipt of Tissues
On arrival, the SkinEthic HCE tissues (Day 6 cultures), were stored at room temperature
prior to transferring into 24-well plates designated 'arrival plates' containing 300 µl of
maintenance medium. It was important to ensure that there were no air bubbles present
under the tissue inserts. The tissues were incubated overnight at 37°C, 5% CO2 in air.
Preparation of Tissues
Using sterile techniques, 1 ml of maintenance medium at room temperature, was
dispensed into the appropriate number of wells of 6-well plates designated 'treatment
plates'. Each well was labelled with details of the treatment and the appropriate
exposure time. Separate treatment plates were used for the test item, negative and
positive controls to avoid the possibility of cross contamination occurring. Before
treatment, the 7-Day old tissues were transferred from the 'arrival plates' into the wells of
the 'treatment plates' containing the maintenance medium.

Vehicle:

unchanged (no vehicle)

Controls:

yes, concurrent positive control

yes, concurrent negative control

Amount / concentration applied:

tissues were treated with 30 pl of the test item
tissues were treated with 30 pl of solution A to serve as negative controls
tissues were treated with 30 pl of 2% w/v SDS to serve as positive controls

Duration of treatment / exposure:

10 minutes

Duration of post- treatment incubation (in vitro):

3 hours

Number of animals or in vitro replicates:

Triplicate

Details on study design:

METHODS
Pre-Test
Assessment of Direct Test Item Reduction of MTT
The MTT assay, a colourimetric method of determining cell viability, is based on
reduction of the yellow tetrazolium salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide) to a blue formazan dye by mitochondrial succinate dehydrogenase
in viable cells.
One limitation of the assay is possible interference of the test item with MTT. A test item
may directly reduce MTT to formazan, thus mimicking dehydrogenase activity of the
cellular mitochondria of viable cells. This property of the test item is only a problem, if at
the time of the MTT test (after the chemical has been rinsed off) there are still sufficient
amounts of the test item on or in the tissues. To identify this possible interference, the
test item was checked for its ability to reduce MTT directly.
30 µl of test item was added to 1 ml of a 0.5 mg/ml MTT solution and incubated at room
temperature in the dark for 3 hours. Untreated MTT solution was used as a control. If
the MTT solution turned blue, the test item was presumed to have reduced the MTT.
The test item was found not to have directly reduced the MTT. However it was noted
that in a preceding in vitro skin irritation test, Harlan Laboratories Ltd project number
41100729, the test item had demonstrated the ability to directly reduce MTT. Therefore,
for precautionary reasons the following procedure, employing freeze-killed tissues that
possess no metabolic activity but absorb and bind the test item like viable tissues, was
performed.
In addition to the normal test procedure, the MTT reducing test item was applied to one
freeze-killed tissue. One freeze-killed tissue remained untreated. The untreated
freeze-killed tissue demonstrates a small amount of MTT reduction due to residual
reducing enzymes.
Freeze-killed tissues were prepared by placing untreated SkinEthic HCE tissues in a
freezer (-14 to -30°C) overnight. Once killed, the tissues were stored in the freezer.

Main Test
Triplicate tissues were treated with 30 µl of the test item for 10 minutes. The tissues
were dosed at regular timed intervals to allow for the period taken to rinse each insert
following exposure and to ensure each tissue received an equal exposure time.
Triplicate tissues were treated with 30 µl of solution A to serve as negative controls and
triplicate tissues were treated with 30 µl of 2% w/v SDS to serve as positive controls.
The plates were incubated at 37°C, 5% CO2 in air during the exposure time.
At the end of the relevant exposure period, each tissue insert was removed from the well
using forceps and rinsed using a wash bottle containing Dulbecco's Phosphate Buffered
Saline (DPBS) without Ca++ and Mg++. Rinsing was achieved by filling and emptying
each tissue insert using a constant soft stream of DPBS to gently remove any residual
test item. Excess DPBS was removed by blotting the bottom of the insert with absorbent
paper. Each tissue was placed into a pre-labelled 24-well plate designated 'holding
plate' containing 300 µl of maintenance medium (at room temperature) until all the
tissues were rinsed. Following rinsing, the tissues (two per group) were transferred to a
pre-labelled 24-well plate designated WTI Loading plate' containing 300 µl of a
0.5 mg/ml MTT solution freshly prepared in maintenance medium. The MTT loading
plate was placed into an incubator for approximately three hours at 37°C, 5% CO2 in air.
At the end of the incubation period, the tissues were visually examined and the degree of
MTT staining evaluated (qualitative evaluation of tissue viability). The inserts were rinsed
twice with phosphate buffered saline and blotted on absorbent paper to remove residual
MTT solution and transferred to a pre-labelled 24-well plate designated NTT extraction
plate' containing 0.75 ml of Isopropanol in each of a sufficient number of wells. An extra
0.75 ml of Isopropanol was added onto each tissue and the plate sealed to prevent
Isopropanol evaporation. The plate was wrapped in aluminium foil (to protect from light)
and allowed to stand overnight at room temperature to extract the formazan crystals out
of the tissue.
At the end of the extraction period, each tissue insert was pierced with a pipette fitted
with a 1000 µl tip and the extraction solution forced vigorously up and down through the
tissue insert until a homogeneous solution was obtained. The empty inserts were
discarded. For each tissue triplicate 200 µl samples were transferred to the appropriate
wells of a pre-labelled 96-well plate. 200 µl of Isopropanol alone was added to three
wells designated as 'blanks'. The optical density was measured (quantitative
measurement of tissue viability) at 540nm (OD540) using the Anthos 2001 microplate
reader.
Tissue Histology
One tissue for each treatment group was retained for possible tissue histopathology.
The tissues were carefully cut out of the polycarbonate inserts with a sharp scalpel. The
tissues were carefully cut in half. Both halves were placed into a pre-labelled 1.5 ml
Eppendorf tube containing 1 ml of 10% Formalin and stored at room temperature.

INTERPRETATION OF RESULTS
The mean OD540 values of the duplicate tissues were calculated. Each of these OD540
values had already been corrected for blanks by the microplate reader.
The relative mean tissue viability (percentage of the negative control) was calculated as
follows:
Relative mean viability (%)= (mean OD540 of test item/ mean OD540 of negative control) x 100

ASSAY ACCEPTANCE CRITERION
The results of the assay are considered acceptable if the following assay acceptance
criterion was achieved:
Assay Acceptance Criterion: Positive Control
The assay meets the acceptance criterion for an acceptable test if the relative mean
tissue viability for the positive control treated tissues is <60% relative to the negative
control treated tissues.

Irritation parameter:

other: Relative Mean Viability (%)

Value:

104.4

Vehicle controls validity:

not applicable

Negative controls validity:

valid

Positive controls validity:

valid

Other effects / acceptance of results:

Assessment of Direct Test Item Reduction of MTT
An assessment found the test item was able to directly reduce MTT in a preceding
in vitro skin irritation test, Harlan Laboratories Ltd project number 41100729. Therefore,
an additional procedure using water-killed tissues was performed during the
determination of skin irritation potential. However, the results obtained showed no
degree of interference due to direct reduction of MTT occurred. It was therefore
considered unnecessary to use the results of the freeze-killed tissues for quantitative
correction of results or for reporting purposes.

Assessment of Eye Irritation Potential
The relative mean viability of the test item treated tissues after a 10-Minute exposure
period was 104.4%.
It was considered unnecessary to proceed with tissue histopathology.

Assay Acceptance Criterion
The quality criterion required for the acceptance of results in the test was satisfied.

Interpretation of results:

other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008

Executive summary:

Introduction.

The purpose of this study was to determine the eye irritation potential of

the test item using the SkinEthic Reconstructed Human Corneal model (HCE, SkinEthic

Laboratories, Nice, France) after a treatment period of 10 minutes. The test is based on

the hypothesis that irritant chemicals are able to penetrate the corneal epithelial tissue

and are sufficiently cytotoxic to cause cell death.

Methods.

The experimental design of the study consists of a test for direct reduction of

MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) by the test item

followed by the main test.

For the main test, triplicate SkinEthic tissues were treated with 30 µl of the test item for

10 minutes. Triplicate tissues treated with 30 µl of Solution A served as the negative

control and triplicate tissues treated with 30 µl of 2% w/v Sodium Dodecyl Sulphate

served as the positive control.

At the end of the exposure period each SkinEthic tissue was rinsed. The rinsed tissues

(two per group) were taken for MTT loading. The remaining tissues were retained for

possible histopathology. Following MTT loading the reduced MTT was extracted from

the tissues.

After extraction the absorbency of triplicate aliquots of the extracted MTT solution for

each SkinEthic tissue was measured. The optical density was measured at 540 nm

(OD540). Data are presented in the form of percentage viability (MTT conversion relative

to negative controls).

The test item was classified according to the following criteria:

i) If the percentage relative mean tissue viability was ≥60% the test item was

considered to be non-irritant (NI).

ii) If the percentage relative mean tissue viability was <60% the test item was

considered to be an irritant (I).

Results.

The relative mean viability of the test item treated tissues after a 10-Minute

exposure period was 104.4%.

It was considered unnecessary to proceed with tissue histopathology.

Quality criteria.

The quality criteria required for acceptance of results in the test were

satisfied.

Conclusion.

According to the study plan followed the test item was considered to be a

Non-Irritant (NI).

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion

Endpoint conclusion:

no study available

Additional information

Skin

The skin irritating properties of the target substance Monoesters of C16 and C18 (branched and linear) fatty acids with decan-1-ol were assessed in an in vitro skin irritation test performed according to OECD guideline 439 and in compliance with GLP (Harlan, 2011a). The purpose of this test was to evaluate the skin irritation potential of the test item using the EPISKIN™ reconstructed human epidermis model after a treatment period of 15 minutes followed by a post-exposure incubation period of 42 hours. The relative mean tissue viability for the positive control treated tissues was ≤40%. The mean OD540 for the negative control treated tissues was ≥0.6 and the standard deviation value of the percentage viability was ≤18%. The negative and positive control acceptance criteria were therefore satisfied.

Based on the results of this study the relative mean viability of the test item treated tissues was 93.6% after the 15 min exposure period. Therefore, the target substance was considered to not show irritating/corrosive potential in the EPISKIN™ reconstructed human epidermis model. The substance is identified as not requiring classification according to GHS and CLP.

Eye

The eye corrosive properties of the target substance Monoesters of C16 and C18 (branched and linear) fatty acids with decan-1-ol were assessed in an in vitro eye irritation study according to OECD guideline 492 and in compliance with GLP (Harlan, 2011b). The purpose of this study was to determine the eye irritation potential of the test item using the SkinEthic Reconstructed Human Corneal model after a treatment period of 10 minutes. The positive and negative control was considered to be valid, respectively. Based on the results of this study the relative mean viability of the test item treated tissues was 104.4% after the 10 min exposure period. Therefore, the target substance was considered to not show irritating/corrosive potential in the SkinEthic Reconstructed Human Corneal model. The substance is identified as not requiring classification according to GHS and CLP.

Justification for classification or non-classification

The available data on skin and eye irritation do not meet the classification criteria according to Regulation (EC) No. 1272/2008 and are therefore conclusive but not sufficient for classification.